Category Archives for Health & Wellness

US Senate Special Committee on Aging holds its First Hearing on Menopause

Published in RINewsToday on September 21, 2026

For generations, menopause was a health issue that many women were expected to deal with on their own, quietly. Last week, the U.S. Senate Special Committee on Aging took the issue into the public discussion, holding the first congressional hearing devoted exclusively to menopause.

The Sept. 16 hearing brought congressional attention to an issue affecting millions of American women navigating perimenopause, menopause and post-menopause. Approximately 2 million more women enter menopause each year.

Menopause affects women differently, but the symptoms can upend daily life. Women may experience hot flashes, vaginal dryness, insomnia, migraine headaches, brain fog, heart palpitations, mood changes, and changes in metabolism. For some, these symptoms become debilitating, disrupting daily and work routines and quality of life.

Senate Aging Committee Chairman Rick Scott (R-FL) and Ranking Member Kirsten Gillibrand (D-NY) convened the hearing, titled “Half the Country, Zero Hearings: Meeting the Moment to End the Menopause Care Gap in America,” to examine what lawmakers call the nation’s “menopause care gap.”

Medical experts, researchers, and women’s health advocates testified about the lack of research, physician training, and access to treatment.

The Senate Aging Committee hearing was a critical step in elevating this issue to determine what’s needed to improve medical research, training, and care for women experiencing menopause,” said Gillibrand in her opening statement.

“Menopause affects half of the population. For generations, women have been told to suffer in silence. I’m done with this silence,” she said.

Even though women in midlife make up a significant portion of the U.S. population, Gillibrand called menopause “one of the most under-researched, undertreated, and under-discussed” health issues in the nation. She pointed to estimates that less than 1% of federal women’s health research funding goes to menopause.

Gillibrand also noted that about 80% of OB-GYN residents report feeling ill-prepared to discuss menopause or its symptoms. The result, she said, is that many women seeking medical care are left without adequate treatment.

Menopause care also carries an economic cost. Gillibrand cited a Mayo Clinic study estimating that menopause costs the U.S. economy $26.6 billion annually, including $1.8 billion in lost work time.

“There’s simply no excuse for the lack of resources and information to help every woman navigate menopause and the challenges that come with it,” said Scott in his opening statement.

Scott cautioned that there is no “one-size-fits-all solution.” Instead, he called for women to have access to reliable information, qualified health care providers, and treatment options that allow them to make informed decisions about their health.

Scott also pointed to hormone replacement therapy as a safe treatment option for many women, while noting that lack of education and access can make it difficult for women to obtain appropriate treatment.

“We also need providers who have the most up-to-date training and who can clearly discuss treatment options with their patients,” said Scott, pointing to the shortage of health care providers as another barrier to care.

Scott and Gillibrand also announced that they sent a bipartisan letter requesting the Government Accountability Office to examine how the federal government both coordinates and funds menopause research and care. The senators say the report could help identify remaining gaps in research, education and treatment.

More Research Needed

Federal funding for research advancing menopause care is inadequate, Dr. Jean Wactawski-Wende, a SUNY Distinguished Professor who has conducted women’s health research for more than four decades, charged.

“In 1985, the National Institutes of Health put forward a study…the report said we’re not doing enough research on women…I’d argue we are now 35 years later, and we have not come all that far,” she told the committee.

“Clinical trials are the gold standard of evidence, and we do not have enough of those trials in women, especially in postmenopausal women,” added Wactawski-Wende.

She identified four areas needing greater attention: increased federal research on women’s health throughout the lifespan; chronic disease in aging women; better education and clinical care after menopause; and greater attention to healthy behaviors throughout life.

Dr. Lynne M. Coslett-Charlton, a board-certified gynecologist who has practiced in Northeastern Pennsylvania for 27 years, pointed to the U.S. Food and Drug Administration’s recent changes to warning labels for menopausal hormone therapy as a major shift in women’s treatment.

Coslett-Charlton also voiced concern that women might get menopause advice from social media influencers instead of from qualified clinicians. This could, in turn, lead them to buy unregulated supplements and products.

She noted that the American College of Obstetricians and Gynecologists has increased its educational efforts to steer patients toward safe, evidence-based, and medically appropriate care. Coslett-Charlton and ACOG also support passage of the Advancing Menopause Care and Midlife Women’s Health Act.

Training Doctors to Treat Menopause

Jennifer Weiss-Wolf, executive director of NYU Law’s Birnbaum Women’s Leadership Center, urged Congress to make telehealth part of the solution. She told lawmakers that virtual care could help connect women, particularly those in areas without specialists, to providers knowledgeable about menopause.

But telehealth has its own barriers, she cautioned, including poor internet connectivity and inadequate insurance coverage. Weiss-Wolf also warned that physician education about menopause must improve.

“For those who started residency after 2002 — statistically that amounts to more than half of all practicing OB-GYNs in the U.S. today — the majority have not had meaningful or even any menopause training,” she said.

Weiss-Wolf called for modern clinical trials that include millennial and Gen X women, with racial, ethnic and geographic diversity. She also urged researchers to use technology better to collect data and track symptoms.

She called on lawmakers to pass three federal bills to increase research and attention to women’s health: the Advancing Menopause Care and Midlife Women’s Health Act; the Service Women and Veterans Menopause Research Act; and the Hormone Health Data and Research Act.

“I Want to Feel Like Myself Again”

“When I ask patients what they hope to get from their care, I often hear, ‘I want to feel like myself again,’” said Dr. Suzanne Silverman Fenske, an obstetrician-gynecologist and integrative medicine practitioner who has practiced in New York City for nearly two decades.

“They want their energy back, relief from anxiety, and a sense of control over a body that suddenly feels unfamiliar,” she said, adding that she

Fenske told the Senate panel that before menopause, a woman’s risk of chronic disease is generally lower than a man’s. After menopause, that risk increases. She pointed to heart disease, hip fractures and urinary sepsis among the serious health problems facing older women.

Fenske also raised an issue that receives far less attention — how physicians are reimbursed for treating menopausal women.

“There is not much incentive for physicians to take care of menopausal women,” she told lawmakers.

Fenske said low insurance reimbursement makes it difficult for independent physicians to spend the necessary time with menopause patients. Large hospital networks may be better able to absorb those costs, she said, while smaller independent practices cannot.

Like the other witnesses, Fenske highlighted the lack of minimum standards for menopause education in medical residency programs.

Fenske offered lawmakers a striking comparison: OB-GYN residents are required to complete at least 200 vaginal deliveries, but there is no comparable minimum requirement for menopause education.  She called on Congress to push Medicare and the Departments of War and Veterans Affairs to make menopause education part of accreditation standards.

Black Box Warning Changes and Challenges

Menopause treatment has received renewed federal attention under Health and Human Services Secretary Robert F. Kennedy Jr., who announced in November 2025 that the FDA would begin removing its strongest “black box” warnings about cardiovascular disease, breast cancer and probable dementia from hormone replacement therapies, including estrogen. The first six revised labels were approved in February 2026, reflecting the administration’s position that overly broad warnings had discouraged women from seeking effective symptom relief. The change does not mean hormone therapy is risk-free: treatment remains an individual decision, with the FDA emphasizing initiation of systemic therapy before age 60 or within 10 years of menopause. The boxed warning about endometrial cancer remains for systemic estrogen-only products. On September 3, the FDA said it was working with manufacturers to increase estrogen patch supplies after rising demand made them harder to find.

Rhode Island No. 1 in U.S. Menopause Workplace Protections

On June 24, 2025, Gov. Dan McKee signed into law legislation (S 0361), introduced by Sen. Lori Urso (D-Dist. 8, Pawtucket), to support women experiencing menopause under the state’s fair employment statute—making Rhode Island the first state to enact such workplace protections explicitly. Rep. Karen Alzate (D-Dist. 60, Pawtucket, Central Falls) introduced a companion bill (H 6161), which passed by concurrence.

Rhode Island law already prohibits workplace discrimination based on pregnancy, childbirth, and related conditions. This includes requiring employers to provide reasonable accommodations and protecting individuals from being denied employment opportunities or promotions—or terminated—because of these conditions. The new law adds menopause to this list of protected health conditions.

“Menopause is a difficult and personal subject that has been stigmatized in this country,” said Sen. Urso in a statement announcing the bill’s passage. “But as something that affects half our population, it’s time we recognize it as a workforce issue—especially as our workforce ages along with our population. The current lack of protections contributes to inadequate retirement savings and lost leadership opportunities for women and poses an economic challenge for employers facing workforce shortages and the loss of experienced employees,” she says.

“Menopause is not something women choose to experience, and its effects on the mind and body can significantly impact daily life and job performance,” said Rep. Alzate. “Women should not have to risk being penalized or discriminated against at work due to a naturally occurring biological transition,” she says.

Rhode Island’s new law is paving the way for workplaces that actually support women experiencing menopause—and it sets a great example for the rest of the country to follow.

A Final Note…

For the millions of women now going through menopause — and the millions more who will follow them — the Sept. 16 hearing put an issue long discussed quietly in doctors’ offices and among women themselves squarely before Congress.

Whether the hearing ultimately results in more federal research, better physician training, and improved access to care will depend on what lawmakers do next. But after generations of silence, menopause finally received its first congressional hearing.

To read Scott and Gillibrand’s correspondence to GAO on the federal government’s role in Menopause research and education, go to Gillibrand Scott GAO Letter on Menopause

To watch the Sept. 16 Senate Aging Committee hearing, go to Half the Country, Zero Hearings: Meeting… | Senate Committee On Aging.

To read about RI’s new Menopause law, go to Rhode Island First in Nation to Add Workplace Protections for Women Experiencing Menopause – Herb Weiss

___

URI Lecture on Healthspan, Not Just Lifespan, in Aging Well 

Published in RINewsToday on April 20, 2026

Over 300 people packed Edwards Auditorium on the University of Rhode Island’s (URI) Kingston Campus on April 7th to attend the 20th annual Malford Thewlis Lecture on Gerontology and Geriatrics. This year, Dr. Laura Kubzansky from the Harvard T.H. Chan School of Public Health spoke, offering research-based, practical tips for living longer and better.

Each year, URI’s lecture highlights important issues related to aging, with particular attention given to policies and programs affecting older adults. Dr. Phillip G. Clark, director of URI’s Program in Gerontology and the Rhode Island Geriatric Education Center, expressed excitement in focusing on personal attributes and longevity at this lecture.

Clark, who serves as emcee, explained that the lecture aims to unite different fields and engage people outside academia. “We show that every field contributes to understanding aging,” he said, adding, “we work hard to keep it accessible—grounded in science but understandable to the general public.”

This message is particularly relevant to Rhode Island. After Clark introduced the event, URI Provost Barbara Wolfe welcomed everyone and highlighted that more than 20% of Rhode Islanders are now aged 65 or older, achieving “super-aging” status. She emphasized that this demographic shift will significantly affect the state’s future budget.

Wolfe also highlighted that by 2050, about 2 billion people worldwide will be age 60 and over, underscoring the significance of the Ocean State’s graying population.

“As a public flagship university, we believe it’s our responsibility to get involved with important social, economic, and policy issues like aging,” says Wolfe.

Building on Wolfe’s remarks, Kubzansky brought decades of expertise to the lecture. She has studied how psychological well-being connects to physical health. Her research examines both traditional risk factors and how traits like optimism and social connection affect health over time.

The Harvard professor has led or co-led many research projects funded by organizations such as the Veterans Administration, the National Institutes of Health, and the Robert Wood Johnson Foundation. She is also a fellow of the American Psychological Association and the Academy of Behavioral Medicine Research.

Focusing on “Healthspan” Rather Than Only Lifespan

In her one-hour lecture, “Optimism and Kindness: Ingredients for a Long and Healthy Life,” Kubzansky urged researchers and the public to rethink how we approach aging. She explained that we should aim not only to live longer, but to remain healthy for more years, free from long-term illness or disability.

Kubzansky describes an “asset-based approach” to health as part of this new way of thinking. This approach means focusing on positive resources or strengths—such as optimism, kindness, and strong relationships—rather than only on problems like stress or depression.

Meanwhile, she suggested that researchers should also study how these positive traits and experiences influence health.  She explained that for a long time, physicians doubted whether these factors truly affect physical health. But now, research increasingly shows their impact.

Kubzansky cited studies showing that activities such as volunteering, spending time in nature, and building social connections improve health and extend life.

She also explained that negative experiences, such as loneliness or post-traumatic stress disorder, increase the risk of chronic diseases like heart disease.

“The key question,” she said, “is whether positive factors do more than just show the absence of something negative, and if they actually offer their own unique benefits.”

Kubzansky cited a study that suggests optimistic people live about 15% longer and are 24% more likely to age in good health. These benefits extend beyond the absence of depression.

This leads to an important question for researchers: ” She asks, can improving mental well-being also improve one’s physical health?

“If we can improve psychosocial functioning,” Kubzansky said, “we may also be able to improve physical health later on. That’s a very promising idea for healthy aging.”

Kubzansky discussed a large United Kingdom study that found people who volunteer or donate to charity experience less chronic pain years later. She noted that another long-term study links loneliness to a much higher risk of heart disease.

One of the most striking research findings Kubzansky shared came from the Baltimore Experience Corps Study. It showed that older adults who volunteered slowed the decline in brain volume, essentially turning back the clock on brain aging by about three years.  She found these results both “striking and encouraging.”  She said, “They’re solid, have been repeated in other studies, and show actions people can really take.”

At the end of the lecture, the question and answer session allowed Kubzansky to discuss topics she hadn’t covered earlier. She talked about practical issues, such as the roles and impacts of pets, family, and faith communities on health; research topics, such as causality and financial differences; and broader social questions, such as optimism among younger people. These conversations helped connect her research to real-life situations.

 A Rhode Island Gerontologist’s Perspective

For URI’s Clark, this year’s Malford Thewlis Lecture on Gerontology and Geriatrics demonstrated that researchers increasingly approach aging in new ways.

“There’s more focus now on human flourishing,” he said, emphasizing Kubzansky’s work at Harvard as a prime example. He stressed that this research challenges old assumptions about aging.

“Many people tend to associate aging with decline,” Clark said. “But research tells us that’s not the whole story,” he continued.

Clark said what stood out most to him during Kubzansky’s presentation was the idea that people have more control over their health than they might realize. “Each of us can develop habits and ways of thinking that improve our chances of living longer and staying healthier,” he said.

Many of these new habits are simple and easy to start, says Clark, including volunteering, staying active, spending time outdoors, or keeping in touch with friends. Even small things, such as caring for a pet or gardening, can make a difference, he says.

For people who have trouble getting around, connecting with friends or family by phone, joining online groups, taking virtual classes, or writing letters can be meaningful. The most important thing is to find activities—big or small—that work for each person and help them build positive connections with others.

Clark sees loneliness as a major social problem that the entire community and system must address—not just individuals.

Volunteering stands out in particular. “People often gain as much or even more from it than those they help,” Clark observed. Having a sense of personal agency is central to all of this. While genetics plays a role, Clark pointed out that research shows we control about 30 percent of our lifespan.

“The takeaway of the lecture,” he said, “is that a positive outlook matters. Even when things are difficult, there are ways to respond that support better health.”

In summary, Kubzansky’s lecture aimed to change how people think about aging, moving beyond just a medical view to one that also values psychological and social well-being. She encouraged everyone—academics, URI students, and community members—to think more broadly about what it means to age well.

Hopefully, her evidence-based arguments may inspire Congress, state policymakers, and public health leaders to allocate more funding to programs that foster social connections, kindness, and a sense of purpose. Attendees heard Kubzansky make a strong scientific case for volunteering, maintaining strong social ties, staying positive, and looking forward. Yes, these practical steps can extend not just your lifespan, but also your healthspan.

In 2006, URI started the Malford Thewlis Lecture on Gerontology and Geriatrics to get people talking and thinking about aging. It is named after Dr. Malford W. Thewlis, a pioneer in geriatric medicine and co-founder of the American Geriatrics Society in 1942. He lived in Wakefield and wrote an early textbook on geriatrics, “The Care of the Aged: Geriatrics,” first published in 1919. He was also an amateur magician and a member of the International Brotherhood of Magicians.

To view Kubzansky’s lecture, go to

2026 Thewlis Lecture “Optimism and Kindness: Ingredients for a Long and Healthy Life” Laura Kubzansky

Rhode Island PR Campaign to Reduce Older Adult Overdoses

Published in RINewsToday on February 16, 2026

Four months ago, the State of Rhode Island joined an estimated 5,000 community coalitions across the nation and U.S. territories to participate in the 2025 National Substance Use and Misuse Prevention Month. The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, organizes this annual federal initiative to highlight the importance of early intervention and community-based prevention strategies.

During November, the State launched its 2025 public awareness campaign titled No Matter Why You Use, aimed at preventing overdose deaths among adults ages 45 to 64 and older. This demographic group faces unique and often complex health risks that increase the likelihood of fatal overdose, making the campaign an important component of the Ocean State’s comprehensive strategy to reduce overdose deaths and improve lives.

The initiative focuses on aging adults who use substances, providing education and resources to help them feel more connected. “It’s also about eliminating stigma and amplifying the voices of those with lived experience,” said Cathy Schultz, Director of the Governor’s Overdose Task Force, in the statement announcing the program.

The statement also included comments from Linda Mahoney of the state’s Behavioral Healthcare, Developmental Disabilities & Hospitals (BHDDH), who emphasized the campaign’s creative approach: “The approach we’ve used is designed to elicit a reaction of ‘this is my struggle,’ ‘that could be my friend,’ or ‘that could be my parent.’ The average person doesn’t typically connect substance use with older adults, but that’s part of the issue we face. If we can raise greater awareness of this reality, we can make meaningful strides in prevention, recovery, and eliminating stigma.”

Maria Cimini, Director of the Rhode Island Office of Healthy Aging, highlighting the state’s responsibility as its older adult population grows. “We must see the full humanity of older adults and confront the issues that too often remain hidden. Substance use is not a moral failing—it’s a public health challenge. By meeting people where they are, connecting them to care, and breaking the silence around stigma, we can build stronger, healthier communities for everyone.”

Data Reveals Rising Overdose Risks for Older Rhode Islanders

According to Joseph Wendelken, RI Dept. of Health’s Public Information Officer, national rates of accidental and undetermined fatal overdoses declined from 2023 to 2024 among adults ages 55–64 (from 51.8 to 41.1 per 100,000) and those 65 and older (from 13.4 to 12.5 per 100,000).

Wendelken noted that Rhode Island, however, experienced different trends. During the same period, the overdose rate increased among adults ages 55–64 (from 51.6 to 63.5 per 100,000) but decreased among those 65 and older (from 15.6 to 12.4 per 100,000).

While much of the national conversation about overdose focuses on younger populations, research shows that middle-aged and older Rhode Islanders often struggle with co-existing physical and mental health conditions, chronic pain, isolation, stigma, and limited access to care — factors that can contribute to rising rates of substance use and overdose, says RIDOH.

Among the key statistics driving the public relations campaign are findings from Rhode Island’s 2024 fatal overdose data. Individuals ages 45 to 64 are experiencing accidental drug overdose deaths at significantly higher rates than the statewide average.

Compared to previous years, the Health Dept. says that the rate of accidental drug overdose deaths continues to rise among individuals ages 55 to 64 in Rhode Island. Most overdose deaths in this age group (87%) occurred in private settings, such as homes.

Stimulants — including cocaine, crack cocaine, methamphetamine, and amphetamines — contributed to 65% of fatal overdoses in this age group, reflecting a growing public health concern beyond opioid-related deaths. Fentanyl was involved in more than half (51%) of fatal overdoses, underscoring its continued role as a primary driver of overdose deaths. A combination of fentanyl and cocaine contributed to 34% of overdoses in this population.

The greatest proportion of overdoses in this age group occurred among males (69%) and non-Hispanic white individuals (74%).

A Statewide Strategy to Prevent Overdose and Save Lives

“The No Matter Why You Use campaign raises awareness of substance use and overdose risks among middle-aged and older adults, provides clear prevention information, and directs Rhode Islanders to PreventOverdoseRI.org for treatment and recovery resources,” said Wendelken. Educational materials have been distributed to hundreds of community partners, including senior centers, healthcare providers, libraries, senior housing sites, and recovery community centers.

The No Matter Why You Use campaign is being led in partnership by the Rhode Island Executive Office of Health and Human Services (EOHHS), BHDDH, OHA, and RIDOH. .

This data-driven campaign supports Gov. Dan McKee’s Overdose Task Force “Roadmap,” which is built on four pillars: strengthening comprehensive prevention; expanding harm reduction and rescue efforts; increasing engagement in treatment; and supporting recovery,” Wendelken explained.

The state initiative is guided by cross-cutting strategies designed to promote an equitable response to the overdose epidemic. These strategies include embedding racial equity across all pillars; strengthening governance and community engagement; expanding data capacity and surveillance; and addressing social determinants of health throughout each pillar.

According to Wendelken, this evidence-informed approach aligns with Rhode Island’s broader overdose prevention strategy and ongoing efforts to save lives.

The state partnered with RDW Group on the No Matter Why You Use campaign. The initiative is based on formative research that included in-depth interviews with subject-matter experts and individuals with lived experience — including people in recovery, counselors, social workers, community advocates, and physicians. These authentic voices helped shape the campaign’s messaging, which emphasizes the impact of stigma, hopelessness, and emotional distress as common triggers for substance use among aging adults who may feel isolated or disconnected.

The campaign’s powerful, portrait-style imagery and first-person messaging acknowledge that people use substances for complex reasons — including isolation, pain, trauma, anxiety, and depression — while centering compassion at its core: No matter why you use, your life matters. Hope and help are here, adds RIDOH.

You can find stories of local Rhode Islanders sharing their powerful recovery stories on the RIDOH (go to https://pori.soapboxx.com).

Designed to help individuals feel safe, seen, and supported, the campaign connects Rhode Islanders to local treatment, recovery, and harm reduction resources at PreventOverdoseRI.org. Its media strategy uses data-driven insights from fatal overdose heat maps to target placements for aging adult audiences. Outreach includes digital advertising on social media, website and app display ads, local and streaming radio spots, and advertisements on gasoline pump televisions.

RIDOH notes that The No Matter Why You Use campaign also includes grassroots outreach to more than 250 organizations statewide. Its launch is part of a comprehensive and ongoing effort by Rhode Island to address substance use and related public health crises.

From Crisis to Recovery

The state’s new No Matter Why You Use campaign, aimed at reducing overdose deaths and addressing stigma among older adults, marks an important first step in combating substance use disorder, says Diane Dufresne, Director of the Pawtucket Prevention Coalition. The coalition is a community organization dedicated to addressing social issues such as substance use, poverty, and homelessness.

Dufresne emphasizes the importance of using precise, nonjudgmental language like “substance use disorder” to shape public perception and support recovery.

“The state’s campaign sloganis powerful because it centers compassion over judgment and makes one thing clear: every life is worth saving,” says Dufresne, who holds a degree in counseling and has been a certified prevention specialist for five years. She also brings more than 40 years of experience as a registered nurse, this extensive clinical background strengthening  her work in substance use prevention and advocacy.

Drawing on her frontline experience, Dufresne agrees with the state’s assessment that substance use and overdose rates are rising among adults age 45 and older. She attributes this trend in part to limited harm-reduction education available to this generation.

“Many older adults developed addictions through legitimate opioid prescriptions and now face complex health challenges, including dangerous interactions with medications prescribed for coexisting conditions,” she explains.

Dufresne notes that shame and stigma are primary drivers of isolation among older adults, increasing the risk of fatal overdoses. “Older adults are more likely to use substances alone in private settings. “Younger people have received more harm-reduction education and better understand the risks of using alone,” she says.

Dufresne also highlights significant barriers to treatment, including transportation challenges, insurance limitations, technology gaps, and reduced mobility. Addressing these obstacles, she says, will require increased state funding and more targeted outreach efforts.

“Increased funding is necessary for community organizations to expand anti-stigma education, provide training opportunities, and connect older adults with treatment and recovery services,” Dufresne says.

The No Matter Why You Use campaign acknowledges the unique challenges facing this demographic, including limited exposure to modern harm-reduction practices, a higher likelihood of addiction stemming from prescribed opioids, and increased social isolation.

Dufresne advocates pairing Narcan distribution with anti-stigma education and recommends practical strategies to reach isolated seniors.

“Effective outreach should include combined Narcan and anti-stigma training in senior housing and community centers, along with door hangers that provide service information for individuals in private residences,” she says.

Above all, Dufresne stresses that saving lives must remain the priority.

“The act of saving a life should never be influenced by judgments about a person’s history of addiction or previous overdoses,” she says.